Literature DB >> 20571505

A single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou Chinese.

Chao Qiang Jiang1, Bin Liu, Bernard M Y Cheung, Tai Hing Lam, Jie Ming Lin, Ya Li Jin, Xiao Jun Yue, Kwok Leung Ong, Sidney Tam, Ka Sing Wong, Brian Tomlinson, Karen S L Lam, G Neil Thomas.   

Abstract

Single nucleotide polymorphisms (SNPs) in the apolipoprotein A5 (APOA5) gene have been associated with hypertriglyceridaemia. We investigated which SNPs in the APOA5 gene were associated with triglyceride levels in two independent Chinese populations. In all, 1375 subjects in the Hong Kong Cardiovascular Risk Factor Prevalence Study were genotyped for five tagging SNPs chosen from HapMap. Replication was sought in 1996 subjects from the Guangzhou Biobank Cohort Study. Among the five SNPs, rs662799 (-1131T>C) was strongly related to log-transformed triglyceride levels among Hong Kong subjects (β=0.192, P=2.6 × 10(-13)). Plasma triglyceride level was 36.1% higher in CC compared to TT genotype. This association was confirmed in Guangzhou subjects (β=0.159, P=1.3 × 10(-12)), and was significantly irrespective of sex, age group, obesity, metabolic syndrome, hypertension, diabetes, smoking and alcohol drinking. The odds ratios and 95% confidence interval for plasma triglycerides ≥1.7 mmol/l associated with TC and CC genotypes were, respectively, 1.81 (1.37-2.39) and 2.22 (1.44-3.43) in Hong Kong and 1.27 (1.05-1.54) and 1.97 (1.42-2.73) in Guangzhou. Haplotype analysis suggested the association was due to rs662799 only. The corroborative findings in two independent populations indicate that the APOA5-1131T>C polymorphism is an important and clinically relevant determinant of plasma triglyceride levels in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571505      PMCID: PMC2987477          DOI: 10.1038/ejhg.2010.93

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  45 in total

1.  Transferability of tag SNPs in genetic association studies in multiple populations.

Authors:  Paul I W de Bakker; Noël P Burtt; Robert R Graham; Candace Guiducci; Roman Yelensky; Jared A Drake; Todd Bersaglieri; Kathryn L Penney; Johannah Butler; Stanton Young; Robert C Onofrio; Helen N Lyon; Daniel O Stram; Christopher A Haiman; Matthew L Freedman; Xiaofeng Zhu; Richard Cooper; Leif Groop; Laurence N Kolonel; Brian E Henderson; Mark J Daly; Joel N Hirschhorn; David Altshuler
Journal:  Nat Genet       Date:  2006-10-22       Impact factor: 38.330

2.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

3.  Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people.

Authors:  Y Yamada; S Ichihara; K Kato; T Yoshida; K Yokoi; H Matsuo; S Watanabe; N Metoki; H Yoshida; K Satoh; Y Aoyagi; A Yasunaga; H Park; M Tanaka; W Lee; Y Nozawa
Journal:  J Med Genet       Date:  2007-08-31       Impact factor: 6.318

4.  Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke.

Authors:  Viktória Havasi; Zoltán Szolnoki; Gábor Talián; Judit Bene; Katalin Komlósi; Anita Maász; Ferenc Somogyvári; András Kondacs; Mihály Szabó; Lajos Fodor; Anita Bodor; Béla Melegh
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

5.  Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study.

Authors:  Bernard M Y Cheung; Nelson M S Wat; Yu Bun Man; Sidney Tam; G Neil Thomas; Gabriel M Leung; Chun Ho Cheng; Jean Woo; Edward D Janus; Chu Pak Lau; Tai Hing Lam; Karen S L Lam
Journal:  Diabetes Care       Date:  2007-03-02       Impact factor: 19.112

6.  Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study.

Authors:  P Yin; C Q Jiang; K K Cheng; T H Lam; K H Lam; M R Miller; W S Zhang; G N Thomas; P Adab
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

7.  Implications of increased weight and waist circumference on vascular risk in an older Chinese population: the Guangzhou Biobank Cohort Study.

Authors:  G Neil Thomas; X Q Lao; C Q Jiang; Sarah M McGhee; W S Zhang; Peymane Adab; Tai Hing Lam; K K Cheng
Journal:  Atherosclerosis       Date:  2007-09-04       Impact factor: 5.162

8.  APOA5 variants and metabolic syndrome in Caucasians.

Authors:  Harald Grallert; Eva-Maria Sedlmeier; Cornelia Huth; Melanie Kolz; Iris M Heid; Christa Meisinger; Christian Herder; Klaus Strassburger; Anke Gehringer; Markus Haak; Guido Giani; Florian Kronenberg; H-Erich Wichmann; Jerzy Adamski; Bernhard Paulweber; Thomas Illig; Wolfgang Rathmann
Journal:  J Lipid Res       Date:  2007-09-03       Impact factor: 5.922

9.  In vivo characterization of human APOA5 haplotypes.

Authors:  Nadav Ahituv; Jennifer Akiyama; Audrey Chapman-Helleboid; Jamila Fruchart; Len A Pennacchio
Journal:  Genomics       Date:  2007-10-23       Impact factor: 5.736

10.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease.

Authors:  Cristen J Willer; Serena Sanna; Anne U Jackson; Angelo Scuteri; Lori L Bonnycastle; Robert Clarke; Simon C Heath; Nicholas J Timpson; Samer S Najjar; Heather M Stringham; James Strait; William L Duren; Andrea Maschio; Fabio Busonero; Antonella Mulas; Giuseppe Albai; Amy J Swift; Mario A Morken; Narisu Narisu; Derrick Bennett; Sarah Parish; Haiqing Shen; Pilar Galan; Pierre Meneton; Serge Hercberg; Diana Zelenika; Wei-Min Chen; Yun Li; Laura J Scott; Paul A Scheet; Jouko Sundvall; Richard M Watanabe; Ramaiah Nagaraja; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; George Davey-Smith; Alan R Shuldiner; Rory Collins; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Antonio Cao; Francis S Collins; Edward Lakatta; G Mark Lathrop; Michael Boehnke; David Schlessinger; Karen L Mohlke; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330

View more
  7 in total

Review 1.  The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.

Authors:  Mahdi Garelnabi; Kenton Lor; Jun Jin; Fei Chai; Nalini Santanam
Journal:  Clin Biochem       Date:  2012-09-19       Impact factor: 3.281

2.  Relationship of APOA5, PPARγ and HL gene variants with serial changes in childhood body mass index and coronary artery disease risk factors in young adulthood.

Authors:  Lakshmy Ramakrishnan; Harshpal S Sachdev; Meenakshi Sharma; Ransi Abraham; Swami Prakash; Dileep Gupta; Yogendra Singh; Seema Bhaskar; Shikha Sinha; Giriraj R Chandak; Kolli S Reddy; Bhargava Santosh
Journal:  Lipids Health Dis       Date:  2011-05-08       Impact factor: 3.876

3.  Common variants in the genes of triglyceride and HDL-C metabolism lack association with coronary artery disease in the Pakistani subjects.

Authors:  Saleem Ullah Shahid; N A Shabana; Jackie A Cooper; Abdul Rehman; Steve E Humphries
Journal:  Lipids Health Dis       Date:  2017-01-31       Impact factor: 3.876

4.  Association of BUD13-ZNF259-APOA5-APOA1-SIK3 cluster polymorphism in 11q23.3 and structure of APOA5 with increased plasma triglyceride levels in a Korean population.

Authors:  Han-Kyul Kim; Muhammad Ayaz Anwar; Sangdun Choi
Journal:  Sci Rep       Date:  2019-06-05       Impact factor: 4.379

5.  Polymorphisms of the 11q23.3 Locus Affect the Risk and Mortality of Coronary Artery Disease.

Authors:  Tomasz Iwanicki; Joanna Iwanicka; Anna Balcerzyk-Matić; Tomasz Nowak; Katarzyna Mizia-Stec; Paweł Bańka; Artur Filipecki; Jolanta Krauze; Alicja Jarosz; Sylwia Górczyńska-Kosiorz; Anna Ochalska-Tyka; Iwona Żak; Paweł Niemiec
Journal:  J Clin Med       Date:  2022-08-03       Impact factor: 4.964

6.  C771G (His241Gln) polymorphism of MLXIPL gene, TG levels and coronary artery disease: a case control study.

Authors:  Asghar Ghasemi; Hasan Aghajani; Soudabeh Fallah; Mehrdad Assadi; Morteza Seifi
Journal:  Anatol J Cardiol       Date:  2014-02-10       Impact factor: 1.596

7.  Influence of APOA5 Locus on the Treatment Efficacy of Three Statins: Evidence From a Randomized Pilot Study in Chinese Subjects.

Authors:  Sha Hua; Chuanxiang Ma; Jun Zhang; Jing Li; Weiwei Wu; Ning Xu; Guanghua Luo; Jianrong Zhao
Journal:  Front Pharmacol       Date:  2018-04-11       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.